Precipitated cannabinoid withdrawal is reversed by Δ9-tetrahydrocannabinol or clonidine

This publication has 26 references indexed in Scilit:

• Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB 1 receptor antagonist SR 141716A in naive mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
• Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawal
  European Journal of Pharmacology, 2000
• Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain
  European Journal of Pharmacology, 1997
• A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1
  Journal of Biological Chemistry, 1997
• Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States
  Drug and Alcohol Dependence, 1997
• Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
  European Journal of Pharmacology, 1995
• Cardiovascular changes during morphine withdrawal in the rat: Effects of clonidine
  Pharmacology Biochemistry and Behavior, 1983
• CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS
  The Lancet, 1978
• A new device for the rapid measurement of impaired motor function in mice
  Pharmacology Biochemistry and Behavior, 1977
• The effect of withdrawal from cannabis on pentylenetetrazol convulsive threshold in mice
  Psychopharmacology, 1974